Positron Emission Tomography (PET) is becoming an increasingly important tool in managing breast cancer.
This shift is largely due to more PET radiotracers being approved by the...
Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment.
A key breakthrough from...
A recent study conducted by Kelly Metcalfe and colleagues and published in the British Journal of Cancer in 2024, explores the effectiveness of risk-reducing mastectomy (RRM) in...
Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies.
They've completed enrolling participants for a specific...
Recent advancements in the research of hormone therapy resistance in advanced estrogen receptor (ER) positive breast cancers has revealed important considerations for future treatment.
A...
BriaCell Therapeutics Corp., a biotech firm focused on developing new treatments for cancer, recently shared promising results from their studies on breast cancer treatments....
Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...